Joseph F. McGuire - 27 Jul 2022 Form 3 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Chief Financial Officer
Signature
/s/ Joseph F. McGuire
Issuer symbol
MAIA
Transactions as of
27 Jul 2022
Net transactions value
$0
Form type
3
Filing time
27 Jul 2022, 18:33:45 UTC
Next filing
02 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MAIA Stock Options 27 Jul 2022 Common Stock 130,000 $8.00 Direct F1
holding MAIA Stock Options 27 Jul 2022 Common Stock 656 $8.00 Direct F2
holding MAIA Stock Options 27 Jul 2022 Common Stock 1,297 $8.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. 25% of these options vest in 1 year with the remaining options to vest in 36 equal monthly installments beginning on August 16, 2021.
F2 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on July 31, 2021.
F3 Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on August 31, 2021.